Carbamazepine reduces the behavioural manifestations of tinnitus following salicylate treatment in rats

Acta Oto-Laryngologica

Volumn 128, Issue 1, 2008, Pages 48-52

  Zheng, Yiwen ^a   Hooton, Katie ^a   Smith, Paul F ^a   Darlington, Cynthia L ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Carbamazepine; Salicylate; Tinnitus

Indexed keywords

CARBAMAZEPINE; SALICYLIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG EFFICACY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TINNITUS;

ACOUSTIC STIMULATION; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; ASSOCIATION LEARNING; CARBAMAZEPINE; CONDITIONING, CLASSICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING BEHAVIOR; ELECTROSHOCK; FEAR; INJECTIONS, INTRAPERITONEAL; MALE; RATS; RATS, WISTAR; SODIUM SALICYLATE; TINNITUS;

EID: 37549007960     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480701361939     Document Type: Article

References (23)

1. Møller AR. Similarities between severe tinnitus and chronic pain. J Am Acad Audiol 2000;11:115-24.
2. Melding PS, Goodey RJ. The treatment of tinnitus with oral anticonvulsants. J Laryngol Otol 1979;93:111-22.
3. Sanchez TG, Balbani AP, Bittar RS, Bento RF, Camara J. Lidocaine test in patients with tinnitus: rationale of accomplishment and relation to the treatment with carbamazepine. Auris Nasus Larynx 1999;26:411-7.
4. Otoom SA, Alkadhi KA. Action of carbamazepine on epileptiform activity of the verartidine model in CA1 neurons. Brain Res 2000;885:289-94.
5. Reckziegel G, Beck H, Schramm J, Urban BW, Elger CE. Carbamazepine effects on Na+ currents in human dentate granule cells from epileptogenic tissue. Epilepsia 1999;40:401-7.
6. Vreugdenhil M, Wadman WJ. Modulation of sodium currents in rat CA1 neurons by carbamazepine and valproate after kindling epileptogenesis. Epilepsia 1999;40:1512-22.
7. Hulshof JH, Vermeij P. The value of carbamazepine in the treatment of tinnitus. ORL J Otorhinolaryngol Relat Spec 1985;47:262-6.
8. Jastreboff PJ, Brennan JF, Coleman JK, Sasaki CT. Phantom auditory sensation in rats: an animal model of tinnitus. Behav Neurosci 1988;102:811-22.
9. Jastreboff PJ, Brennan JF. Evaluating the loudness of phantom auditory perception (tinnitus) in rats. Audiology 1994;33:202-17.
10. Brennan JF, Jastreboff PJ. Generalization of conditioned suppression during salicylate-induced phantom auditory perception in rats. Acta Neurobiol 1991;51:15-27.
11. Rüttiger L, Ciuffani J, Zenner HP, Knipper M. A behavioral paradigm to judge acute sodium salicylate-induced sound experience in rats: a new approach for an animal model on tinnitus. Hear Res 2003;180:39-50.
12. Short CR, Neff-Davis CA, Hsieh LC, Koritz GD, Malbrough MS, Barker SA, et al. Pharmacokinetics and elimination of salicylate acid in rabbits. J Vet Pharmacol Ther 1991;14:70-7.
13. Graumlich JF, McLaughlin RG, Birkhahan D, Shah N, Burk A, Jobe PC, et al. Carbamazepine pharmacokinetics-pharmacodynamics in genetically epilepsy-prone rats. Eur J Pharmacol 1999;369:305-11.
14. Kaltenbach JA, Afman CE. Hyperactivity in the dorsal cochlear nucleus after intense sound exposure and its resemblance to tone-evoked activity: a physiological model for tinnitus. Hear Res 2000;140:165-72.
15. Heffner HE, Harrington IA. Tinnitus in hamsters following exposure to intense sound. Hear Res 2002;170:83-95.
16. Liu Y, Li X. Effects of salicylate on voltage-gated sodium channels in rat inferior colliculus neurons. Hear Res 2004;193:68-74.
17. Wang HT, Luo B, Zhou KW, Xu TL, Chen L. Sodium salicylate reduces inhibitory postsynaptic currents in neurons of the rat auditory cortex. Hear Res 2006;215:77-83.
18. Liu L, Zheng T, Morris MJ, Wallengren C, Clarke AL, Reid CA, et al. The mechanism of carbamazepine aggravation of absence seizures. J Pharmacol Exp Ther 2006;319:790-8.
19. MacPhee GJ, McPhail EM, Butler E, Brodie MJ. Controlled evaluation of a supplementary dose of carbamazepine on psychomotor function in epileptic patients. Eur J Clin Pharmacol 1986;31:195-9.
20. Wildon JD, Pleuvry BJ, Mawer GE. Impairment of psychomotor function at modest plasma concentrations of carbamazepine after administration of the liquid suspension to naive subjects. Br J Clin Pharmacol 1993;35:14-9.
21. Shea JJ, Harell M. Management of tinnitus aurium with lidocaine and carbamazepine. Laryngoscope 1978;88:1477-84.
22. George RN, Kemp S. A survey of New Zealanders with tinnitus. Br J Audiol 1991;25:331-6.
23. Ahmad S, Fowler LJ, Whitton PS. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. Epilepsy Res 2005;63:141-9.